Continuing 24 Month Results of a Multicenter, Randomized Trial Comparing Three Induction Agents (Alemtuzumab, Thymoglobulin and Basiliximab) with Tacrolimus, Mycophenolate Mofetil and a Rapid Steroid Withdrawal in Renal Transplantation.
AMERICAN JOURNAL OF TRANSPLANTATION（2009）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要